278 related articles for article (PubMed ID: 34503296)
1. Targeting CD82/KAI1 for Precision Therapeutics in Surmounting Metastatic Potential in Breast Cancer.
Viera M; Yip GWC; Shen HM; Baeg GH; Bay BH
Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503296
[TBL] [Abstract][Full Text] [Related]
2. Role of a metastatic suppressor gene KAI1/CD82 in the diagnosis and prognosis of breast cancer.
Al-Khater KM; Almofty S; Ravinayagam V; Alrushaid N; Rehman S
Saudi J Biol Sci; 2021 Jun; 28(6):3391-3398. PubMed ID: 34121877
[TBL] [Abstract][Full Text] [Related]
3. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
Zhou B; Liu L; Reddivari M; Zhang XA
Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
[TBL] [Abstract][Full Text] [Related]
4. EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.
Zhang XA; Lane WS; Charrin S; Rubinstein E; Liu L
Cancer Res; 2003 May; 63(10):2665-74. PubMed ID: 12750295
[TBL] [Abstract][Full Text] [Related]
5. Expression Levels of Tetraspanin KAI1/CD82 in Breast Cancers in North Indian Females.
Singh R; Bhatt ML; Singh SP; Kumar V; Goel MM; Mishra DP; Srivastava K; Kumar R
Asian Pac J Cancer Prev; 2016; 17(7):3431-6. PubMed ID: 27509988
[TBL] [Abstract][Full Text] [Related]
6. Role of Metastasis Suppressor KAI1/CD82 in Different Cancers.
Yan W; Huang J; Zhang Q; Zhang J
J Oncol; 2021; 2021():9924473. PubMed ID: 34306081
[TBL] [Abstract][Full Text] [Related]
7. Requirement of the p130CAS-Crk coupling for metastasis suppressor KAI1/CD82-mediated inhibition of cell migration.
Zhang XA; He B; Zhou B; Liu L
J Biol Chem; 2003 Jul; 278(29):27319-28. PubMed ID: 12738793
[TBL] [Abstract][Full Text] [Related]
8. KAI1/CD82, a tumor metastasis suppressor.
Liu WM; Zhang XA
Cancer Lett; 2006 Aug; 240(2):183-94. PubMed ID: 16260083
[TBL] [Abstract][Full Text] [Related]
9. KAI1/CD82, Metastasis Suppressor Gene as a Therapeutic Target for Non-Small-Cell Lung Carcinoma.
Prabhu VV; Devaraj SN
J Environ Pathol Toxicol Oncol; 2017; 36(3):269-275. PubMed ID: 29283339
[TBL] [Abstract][Full Text] [Related]
10. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients.
Huang CI; Kohno N; Ogawa E; Adachi M; Taki T; Miyake M
Am J Pathol; 1998 Sep; 153(3):973-83. PubMed ID: 9736046
[TBL] [Abstract][Full Text] [Related]
11. Transmembrane interactions are needed for KAI1/CD82-mediated suppression of cancer invasion and metastasis.
Bari R; Zhang YH; Zhang F; Wang NX; Stipp CS; Zheng JJ; Zhang XA
Am J Pathol; 2009 Feb; 174(2):647-60. PubMed ID: 19116362
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of the metastasis suppressor protein KAI1/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma.
Protzel C; Kakies C; Kleist B; Poetsch M; Giebel J
Virchows Arch; 2008 Apr; 452(4):369-75. PubMed ID: 18305955
[TBL] [Abstract][Full Text] [Related]
13. KAI1/CD82 Genetically Engineered Endothelial Progenitor Cells Inhibit Metastasis of Human Nasopharyngeal Carcinoma in a Mouse Model.
Wang G; Zhang L; Zhou Y; Sun Q; Xu H; Cai F; Xiang P; Chen Z; Jiang H
Med Sci Monit; 2018 May; 24():3146-3152. PubMed ID: 29755107
[TBL] [Abstract][Full Text] [Related]
14. KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis.
Malik FA; Sanders AJ; Jiang WG
Histol Histopathol; 2009 Apr; 24(4):519-30. PubMed ID: 19224455
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the correlation of vasculogenic mimicry, Notch4, DLL4, and KAI1/CD82 in the prediction of metastasis and prognosis in non-small cell lung cancer.
Wang Y; Yang R; Wang X; Ci H; Zhou L; Zhu B; Wu S; Wang D
Medicine (Baltimore); 2018 Dec; 97(52):e13817. PubMed ID: 30593175
[TBL] [Abstract][Full Text] [Related]
16. Transduction of KAI1/CD82 cDNA promotes hematogenous spread of human lung-cancer cells in natural killer cell-depleted SCID mice.
Shinohara T; Nishimura N; Hanibuchi M; Nokihara H; Miki T; Hamada H; Sone S
Int J Cancer; 2001 Oct; 94(1):16-23. PubMed ID: 11668473
[TBL] [Abstract][Full Text] [Related]
17. KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor: an immunohistochemical analysis.
Higashiyama M; Kodama K; Yokouchi H; Takami K; Adachi M; Taki T; Ishiguro S; Nakamori S; Yoshie O; Miyake M
Cancer; 1998 Aug; 83(3):466-74. PubMed ID: 9690539
[TBL] [Abstract][Full Text] [Related]
18. Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression.
Bandyopadhyay S; Zhan R; Chaudhuri A; Watabe M; Pai SK; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Pauza ME; Hayashi S; Wang Y; Mohinta S; Mashimo T; Iiizumi M; Furuta E; Watabe K
Nat Med; 2006 Aug; 12(8):933-8. PubMed ID: 16862154
[TBL] [Abstract][Full Text] [Related]
19. Metastasis suppressor KAI1/CD82 attenuates the matrix adhesion of human prostate cancer cells by suppressing fibronectin expression and β1 integrin activation.
Lee HA; Park I; Byun HJ; Jeoung D; Kim YM; Lee H
Cell Physiol Biochem; 2011; 27(5):575-86. PubMed ID: 21691075
[TBL] [Abstract][Full Text] [Related]
20. Exosomal protein CD82 as a diagnostic biomarker for precision medicine for breast cancer.
Wang X; Zhong W; Bu J; Li Y; Li R; Nie R; Xiao C; Ma K; Huang X; Li Y
Mol Carcinog; 2019 May; 58(5):674-685. PubMed ID: 30604894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]